EUVIMEDEUVIMED entdecken
Crossref

26-A-16842-ACC REAL WORLD IMPACT OF TIRZEPATIDE ON CLASS III OBESE PATIENTS UNDERGOING ATRIAL FIBRILLATION ABLATION

Justin Haloot, Tate Truly, Ermias Sori, Irakli Giorgberidze

JACC · 2026-04 · 87 (13) · A64

DOI: 10.1016/j.jacc.2026.02.160 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC, 2026-04. Verfasst von Justin Haloot und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Haloot, J., Truly, T., Sori, E., & Giorgberidze, I. (2026). 26-A-16842-ACC REAL WORLD IMPACT OF TIRZEPATIDE ON CLASS III OBESE PATIENTS UNDERGOING ATRIAL FIBRILLATION ABLATION. JACC, 87(13), A64. https://doi.org/10.1016/j.jacc.2026.02.160

Vancouver

Haloot J, Truly T, Sori E, Giorgberidze I. 26-A-16842-ACC REAL WORLD IMPACT OF TIRZEPATIDE ON CLASS III OBESE PATIENTS UNDERGOING ATRIAL FIBRILLATION ABLATION. JACC. 2026;87(13):A64. doi:10.1016/j.jacc.2026.02.160

BibTeX
@article{Haloot2026,
  author = {Haloot, Justin and Truly, Tate and Sori, Ermias and Giorgberidze, Irakli},
  title = {26-A-16842-ACC REAL WORLD IMPACT OF TIRZEPATIDE ON CLASS III OBESE PATIENTS UNDERGOING ATRIAL FIBRILLATION ABLATION},
  journal = {JACC},
  year = {2026},
  volume = {87},
  number = {13},
  pages = {A64},
  doi = {10.1016/j.jacc.2026.02.160}
}
Kostenlos starten →